We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $2.58M invested in Blueprint Medicines in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 344 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less funds holding

Funds holding: 354 → 5 (-349)

99.54% less ownership

Funds ownership: 99.58% → 0.04% (-100%)

100% less capital invested

Capital invested by funds: $8.24B → $2.58M (-$8.24B)

100% less funds holding in top 10

Funds holding in top 10: 29 → 0 (-29)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 344

Holders
5
Holders Change
-349
Holders Change %
-98.59%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-29
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
344
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$822M
2
BlackRock
BlackRock
New York
-$784M
3
PCM
Pentwater Capital Management
Florida
-$500M
4
State Street
State Street
Massachusetts
-$286M
5
UBS Group
UBS Group
Switzerland
-$278M
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
251
Virtu Financial
New York
– -$389K -3,035 Closed
SG Americas Securities
252
SG Americas Securities
New York
– -$383K -2,988 Closed
DC
253
Diametric Capital
Massachusetts
– -$356K -2,777 Closed
BC
254
Birchview Capital
Vermont
– -$346K -2,700 Closed
N
255
Natixis
France
– -$339K -2,641 Closed
Comerica Bank
256
Comerica Bank
Texas
– -$332K -2,587 Closed
CHAM
257
Clear Harbor Asset Management
Connecticut
– -$331K -2,581 Closed
SPIA
258
Steward Partners Investment Advisory
New York
– -$327K -2,552 Closed
Mirae Asset Global Investments
259
Mirae Asset Global Investments
South Korea
– -$320K -2,495 Closed
Neuberger Berman Group
260
Neuberger Berman Group
New York
– -$310K -2,421 Closed
AB
261
Amalgamated Bank
New York
– -$282K -2,202 Closed
PCM
262
PenderFund Capital Management
British Columbia, Canada
– -$282K -2,200 Closed
ECM
263
Everence Capital Management
Indiana
– -$268K -2,090 Closed
PEAK6
264
PEAK6
Illinois
– -$256K -2,000 Closed
LTAS
265
Linden Thomas Advisory Services
North Carolina
– -$254K -1,985 Closed
Nisa Investment Advisors
266
Nisa Investment Advisors
Missouri
– -$250K -1,950 Closed
CIBC Asset Management
267
CIBC Asset Management
Ontario, Canada
– -$247K -1,928 Closed
PNC Financial Services Group
268
PNC Financial Services Group
Pennsylvania
– -$244K -1,900 Closed
TSS
269
Two Sigma Securities
New York
– -$243K -1,894 Closed
AHL
270
Abel Hall LLC
Louisiana
– -$237K -1,846 Closed
KBC Group
271
KBC Group
Belgium
– -$228K -1,776 Closed
RS
272
R Squared
Hong Kong
– -$226K -1,766 Closed
Commonwealth Equity Services
273
Commonwealth Equity Services
Massachusetts
– -$218K -1,698 Closed
MFG
274
Merit Financial Group
Georgia
– -$213K -1,662 Closed
SLAM
275
Swiss Life Asset Management
– -$210K -1,638 Closed
9 10
11
12 13

BPMC Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q3 2025, worth a combined $2.58M — down 100% from $8.24B a quarter earlier.

Sellers outnumbered buyers: 344 funds closed out of BPMC and 0 opened new positions — a net loss of 344 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $2.06K. The largest seller was Vanguard Group, exiting entirely with an estimated $822M sold.

  • 5 institutional investors held Blueprint Medicines (BPMC) as of Q3 2025, down from 354 in Q2 2025.
  • Funds reported $2.58M of Blueprint Medicines stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Blueprint Medicines positions in Q3 2025 and 344 closed out, a net change of -344 holders.
  • The largest Blueprint Medicines buyer in Q3 2025 was IFP Advisors, an estimated $2.06K added.
  • The largest Blueprint Medicines seller in Q3 2025 was Vanguard Group, an estimated $822M sold.

Based on aggregated 13F filings for Q3 2025.